Resources for Journalists

COVID-19 is a disease caused by the SARS-CoV-2 virus strain, that has not been previously identified in humans. See below for a collection of resources to help you cover this issue (Please note: additional resources are available to journalists who are logged in).

The AusSMC also issues a daily COVID-19 update for registered journalists (click here to view an example). If you would like to receive this email, please go to your profile on MyScimex and select yes beside "Receive COVID-19 Updates?". The email update and this resources page are supported by the Google News Initiative.

Latest COVID-19 news, research, expert reactions and briefings

Show/Hide newsfeed filter Filter by
Type
News for

Choose a location of interest

  1. Did the 4-month COVID-19 lockdown affect Victorians long-term?

    Publicly released: Fri 8 Apr 2022 at 1100 AEST, 1300 NZST

    PLOS ONE

    Victoria's four-month COVID-19 lockdown in 2020 negatively affected the mental health of the state's residents, according to Aussie researchers, who say this impact was not permanent, and ... The team Read more about Did the 4-month COVID-19 lockdown affect Victorians long-term?

    Australia; VIC; ACTMonash University | The Australian National University

  2. Could a sniff test using smelly stuff at home pick up COVID-19?

    Publicly released: Fri 8 Apr 2022 at 0900 AEST, 1100 NZST

    Communications Medicine

    Early use by over 13,000 participants, including 462 who were COVID-positive, found the tool was 79 per cent sensitive at detecting COVID, comparing well to RAT tests. ... on in the brain with Read more about Could a sniff test using smelly stuff at home pick up COVID-19?

    InternationalWeizmann Institute of Science, Bezalel Academy of Fine Arts and Design, Edith Wolfson Medical Center, Tel Aviv University (Israel), Karolinska Institutet and Stockholm University (Sweden), University of Oslo (Norway), University of Tokyo (Japan), Champalimaud Centre for the Unknown (Portugal), University of Florence (Italy)

  3. How do Delta and Omicron symptoms differ for vaccinated people?

    Publicly released: Fri 8 Apr 2022 at 0801 AEST, 1001 NZST

    The Lancet

    Between June 1, 2021, and Jan 17, 2022, the researchers identified 63 002 participants who tested positive for SARS-CoV-2 and reported symptoms in the ZOE app. ... The authors conclude: “We report that Read more about How do Delta and Omicron symptoms differ for vaccinated people?

    InternationalKing’s College London, UK

  4. Motivation - not only attitude - is key when it comes to vaccine decisions

    Publicly released: Fri 8 Apr 2022 at 0400 AEST, 0600 NZST

    PLOS ONE

    Kiwi and Australian researchers sought to understand - and predict - the motivation of individuals to be vaccinated against COVID-19, using a policy response framework. ... They say the results also Read more about Motivation - not only attitude - is key when it comes to vaccine decisions

    Australia; New Zealand; NSWManaaki Whenua - Landcare Research | The University of New England

  5. At-risk Kiwis show strong immune response to Pfizer vaccine

    Publicly released: Thu 7 Apr 2022 at 1200 AEST, 1400 NZST

    She says while the study showed no difference in the antibody immune response in Māori when compared to non-Māori, the rates of infection and hospitalisation from COVID-19 remain higher ... SARS-CoV-2 Read more about At-risk Kiwis show strong immune response to Pfizer vaccine

    New ZealandMalaghan Institute of Medical Research | University of Otago ...

  6. Serious blood clot risk for months after getting COVID-19

    Publicly released: Thu 7 Apr 2022 at 0830 AEST, 1030 NZST

    The BMJ

    Using national registries in Sweden, they identified more than one million people with confirmed SARSCoV-2 infection (the virus responsible for covid-19) between 1 February 2020 and 25 May 2021, Read more about Serious blood clot risk for months after getting COVID-19

    InternationalUmeå University (Sweden), The Open University (UK), University of Helsinki and Helsinki University Hospital (Finland)

  7. Fluvoxamine appears to be an effective option for reducing COVID-19 hospitalisations

    Publicly released: Thu 7 Apr 2022 at 0100 AEST, 0300 NZST

    JAMA Network Open

    Fluvoxamine, a drug usually used as an antidepressant, is highly likely to be able to reduce hospitalisations when used early as a COVID-19 treatment, according to an international meta-analysis. Read more about Fluvoxamine appears to be an effective option for reducing COVID-19 hospitalisations

    InternationalMcGill University Health Centre, Canada

  8. Meddle: the medical Wordle that’s boosting mental health

    Publicly released: Wed 6 Apr 2022 at 1100 AEST, 1300 NZST

    In conjunction with the new Meddle word game, the pair has also established a gofundme campaign to raise funds for COVID-19 vaccinations in developing countries. ... Infections are surging in vulnerable Read more about Meddle: the medical Wordle that’s boosting mental health

    Australia; SAUniversity of South Australia

  9. Super-spreader events may cement new COVID-19 variants

    Publicly released: Wed 6 Apr 2022 at 0901 AEST, 1101 NZST

    Journal of the Royal Society Interface

    Novel variants have prolonged the COVID-19 pandemic, leading to countless infections and deaths. ... Superspreading (one individual infecting many others) is a key feature of COVID-19 persistence. Read more about Super-spreader events may cement new COVID-19 variants

    InternationalFred Hutchinson Cancer Research Center, University of Washington, Seattle, US.

  10. Are our kits and puppers giving us superbugs?

    Publicly released: Wed 6 Apr 2022 at 0801 AEST, 1001 NZST

    European Congress of Clinical Microbiology & Infectious Diseases

    She continues, “Even before the COVID-19 pandemic, antibiotic resistance was one of the biggest threats to public health because it can make conditions like pneumonia, sepsis, urinary tract and Read more about Are our kits and puppers giving us superbugs?

    InternationalUniversity of Lisbon, Portugal

  11. Fourth Pfizer shot gave triple protection from severe COVID-19 in Israel

    Publicly released: Wed 6 Apr 2022 at 0700 AEST, 0900 NZST

    New England Journal of Medicine

    In a new study (abstract only) of over 1. 2 million older Israelis, people given a fourth dose had a 3. ... 5 times lower rate of severe COVID-19 illness in the fourth week afterwards than people with a Read more about Fourth Pfizer shot gave triple protection from severe COVID-19 in Israel

    InternationalWeizmann Institute of Science, Technion–Israel Institute of Technology, the Hebrew Universityof Jerusalem, Israel Ministry of Health, Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel Aviv University (all Israel)

  12. How can we best allocate monoclonal antibodies to manage COVID-19?

    Publicly released: Wed 6 Apr 2022 at 0100 AEST, 0300 NZST

    JAMA Network Open

    status and either as treatment or as a preventative measure after COVID-19 exposure. ... The researchers say COVID-19 patients aged 60 years and older who are not fully vaccinated should be prioritised Read more about How can we best allocate monoclonal antibodies to manage COVID-19?

    InternationalNational University of Singapore, Singapore

  13. Nine in ten kids with prolonged COVID-19 symptoms less active, in survey of parents

    Publicly released: Tue 5 Apr 2022 at 1038 AEST, 1238 NZST

    Future Microbiology

    Researchers have surveyed parents of 510 children who had COVID-19 symptoms that lasted longer than four weeks. ... The authors highlight some important biases, especially that the survey was promoted by Read more about Nine in ten kids with prolonged COVID-19 symptoms less active, in survey of parents

    InternationalFondazione Policlinico Universitario A Gemelli Istituto di Ricovero e Cura a Carattere Scientifico, Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Universita Cattolica del Sacro Cuore, Global Health Research Institute, Istituto di Igiene, Universita Cattolica del Sacro Cuore (Italy), University College London, Imperial College London, Coventry University Group, Long Covid Kids (UK), Sechenov First Moscow State Medical University (Russia)University

  14. BACKGROUND BRIEFING: Influenza in times of COVID-19

    Publicly released: Tue 5 Apr 2022 at 1000 AEST, 1200 NZST

    As our healthcare system is under pressure from each new wave of COVID-19 infections, how will it fare with the pandemic and our upcoming flu season? ... vaccines for specific SARS-CoV-2 strains, similar Read more about BACKGROUND BRIEFING: Influenza in times of COVID-19

    Australia; NSW; VIC; QLDAustralian Science Media Centre | The Peter Doherty Institute for Infection and Immunity ...

  15. No link between vaccination during pregnancy and fetal anomalies

    Publicly released: Tue 5 Apr 2022 at 0100 AEST, 0300 NZST

    JAMA Pediatrics

    Getting vaccinated against COVID-19 while pregnant will not put your baby at risk of a fetal abnormality in the womb, according to international research. ... What The Study Did: The association between Read more about No link between vaccination during pregnancy and fetal anomalies

    InternationalNorthwestern University Feinberg School of Medicine, USA

  16. Parasite thrives if its host survives

    Publicly released: Mon 4 Apr 2022 at 1427 AEST, 1627 NZST

    Ecology and Evolution

    The ability of species to adapt to existential challenges depends on the host’s ability to ‘discover’ new strategies via random mutations, and the greater the number of individuals in a Read more about Parasite thrives if its host survives

    Australia; NSW; SAFlinders University | Western Sydney University | South Australian Museum

  17. Pre-surgery support could help elective surgery patients quit smoking

    Publicly released: Mon 4 Apr 2022 at 0001 AEST, 0201 NZST

    Medical Journal of Australia

    an offer of mailed NRT (according to reported daily smoking: 1‒9 cigarettes/day, 2 mg lozenges; 10‒15/day, 7‒14 mg patches [3 weeks] and 2 mg lozenges; > ... Of 748 eligible participants (control, Read more about Pre-surgery support could help elective surgery patients quit smoking

    Australia; VICMonash University | The University of Melbourne

  18. More infants are getting infected with Omicron, but severe disease is rarer

    Publicly released: Sat 2 Apr 2022 at 0200 AEDT, 0400 NZDT

    JAMA Pediatrics

    The researchers say about 1-1. 5 infants in 1000 caught COVID-19 during Delta, but that rose to 2. ... What The Study Did: The results of this study including 650,000 children suggest that the incidence Read more about More infants are getting infected with Omicron, but severe disease is rarer

    InternationalCase Western Reserve University School of Medicine, USA

  19. Molnupiravir eliminates COVID-19 virus in just 3 days, improves symptoms quicker

    Publicly released: Fri 1 Apr 2022 at 0901 AEDT, 1101 NZDT

    European Congress on Clinical Microbiology & Infectious Diseases (ECCMID)

    New virology data shows the investigational COVID antiviral drug molnupiravir eliminates actively infectious SARS-CoV-2 virus by day 3 of starting therapy New data to be presented at this Read more about Molnupiravir eliminates COVID-19 virus in just 3 days, improves symptoms quicker

    InternationalScience Media Centre (New Zealand) | MSD

  20. When experiencing the threat of COVID-19, people became more generous

    Publicly released: Fri 1 Apr 2022 at 0200 AEDT, 0400 NZDT

    Scientific Reports

    Selfish behaviours may derive from fear and self-preservation, and early stages of the COVID-19 pandemic saw examples of selfish behaviour such as stockpiling. ... Ariel Fridman and colleagues examined Read more about When experiencing the threat of COVID-19, people became more generous

    InternationalUniversity of California, USA

Show Results

  1. 10
  2. 20
  3. 50